Santa Cruz Biotechnology supplies a comprehensive collection of ZFAT monoclonal antibodies for research focused on understanding ZFAT protein functions. ZFAT monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ZFAT protein functions as a transcription factor that regulates immune responses and maintains essential roles in T cell development and function. Research has shown that ZFAT influences various cellular processes, including apoptosis and differentiation. ZFAT has emerged as a significant target for investigating immune system disorders and developing therapeutic strategies. Studying ZFAT expression and activity can reveal important mechanisms underlying autoimmune diseases and other immune-related conditions. Researchers worldwide utilize ZFAT monoclonal antibodies to conduct detailed analyses of cellular pathways and molecular interactions. ZFAT monoclonal antibodies enable precise detection and characterization of ZFAT in diverse experimental settings. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of immune system regulation and disease mechanisms.